Duke University patent applications published on July 11th, 2024
Contents
- 1 Patent applications for Duke University on July 11th, 2024
- 1.1 VACCINE COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF URINARY TRACT INFECTIONS (18277150)
- 1.2 NON-IMMUNOGENIC POEGMA-APTAMER CONJUGATES (18277915)
- 1.3 Compositions For and Methods of Improving Gene Therapy (18547332)
- 1.4 COMPOSITIONS COMPRISING A VAGINAL MOLD AND METHODS OF USE THEREOF (18405331)
- 1.5 Compositions and methods for improved malonyl-CoA biosynthesis using 2-stage dynamic metabolic control (18187102)
- 1.6 FUSION MOLECULES OF RATIONALLY-DESIGNED DNA-BINDING PROTEINS AND EFFECTOR DOMAINS (18352037)
- 1.7 RATIONALLY-DESIGNED MEGANUCLEASES WITH ALTERED SEQUENCE SPECIFICITY AND DNA-BINDING AFFINITY (18472881)
- 1.8 SPLICE-SWITCHING OLIGONUCLEOTIDES AND METHODS OF USE (18402154)
- 1.9 METHYLATION MARKERS FOR THE TREATMENT OF GLIOBLASTOMA AND OTHER CANCERS (18548025)
Patent applications for Duke University on July 11th, 2024
VACCINE COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF URINARY TRACT INFECTIONS (18277150)
Main Inventor
Soman Abraham
NON-IMMUNOGENIC POEGMA-APTAMER CONJUGATES (18277915)
Main Inventor
Ashutosh Chilkoti
Compositions For and Methods of Improving Gene Therapy (18547332)
Main Inventor
Aravind Asokan
COMPOSITIONS COMPRISING A VAGINAL MOLD AND METHODS OF USE THEREOF (18405331)
Main Inventor
Cassandra Kisby
Compositions and methods for improved malonyl-CoA biosynthesis using 2-stage dynamic metabolic control (18187102)
Main Inventor
Michael Lynch
FUSION MOLECULES OF RATIONALLY-DESIGNED DNA-BINDING PROTEINS AND EFFECTOR DOMAINS (18352037)
Main Inventor
Derek Jantz
RATIONALLY-DESIGNED MEGANUCLEASES WITH ALTERED SEQUENCE SPECIFICITY AND DNA-BINDING AFFINITY (18472881)
Main Inventor
James Jefferson Smith
SPLICE-SWITCHING OLIGONUCLEOTIDES AND METHODS OF USE (18402154)
Main Inventor
Jennifer Freedman
METHYLATION MARKERS FOR THE TREATMENT OF GLIOBLASTOMA AND OTHER CANCERS (18548025)
Main Inventor
David ASHLEY
